FDA Could Approve Updated COVID-19 Vaccines Soon
George Washington University
March 2020 was a scary time for Adam Cardello and Zohra Ahmadi Cardello. It was the start of the COVID-19 pandemic, and their first child, Safaa Cardello, had just been born more than three months prematurely.
A new animal study shows that exposure to immune-stimulating proteins left behind by COVID-19 leads to lower cortisol, brain inflammation and a heightened reaction to subsequent stressors.
A unique influenza vaccine candidate that’s inhaled and based on technology developed by University of Wisconsin–Madison researchers is safe and could bolster protection against seasonal and pandemic influenza for people vulnerable to severe disease when they receive it in addition to the annual flu shot.Those are the results of a randomized, controlled trial of the vaccine candidate, administered in nasal spray form in conjunction with the annual shot to a group of 65- to 85-year-olds in 2022.
People with multiple sclerosis (MS) have an increased risk of severe coronavirus infection, but there has been concern regarding potential relapse after vaccination. A new study finds that people with MS may not have a higher risk of relapse after COVID-19 vaccination. The study is published in the August 14, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
School is right around the corner. Are you and your child ready for the new year? A Penn State Health expert offers a rundown of everything you need to keep your child healthy for 2024-2025.
The human parvovirus B19 activity in the United States is increasing, according to the CDC. ...
Respiratory infections can be severe, even deadly, in some individuals, but not in others. Scientists at St. Jude Children’s Research Hospital, the Peter Doherty Institute for Infection and Immunity and other collaborators have gained new understanding of why this is the case by uncovering an early molecular driver that underpins fatal disease.
The CDC says the summer Covid surge came earlier this year than last year. ...
Working with human stem cells that form a kind of “mini intestine-in-a-dish,” Johns Hopkins Medicine scientists say they have found several molecular mechanisms for COVID-19-related diarrhea, suggesting potential ways to control it.
Phylex Biosciences has achieved positive results with its new mRNA nanoparticle vaccine against the Nipah virus in an immunogenicity study conducted in collaboration with scientists of the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.
Professor Nelesh Govender was awarded one of 7 prestigious 5-year UK National Institute for Health and Care Research (NIHR) Global Research Professorships.